On March 26, people around the world come together to raise awareness of epilepsy and the challenges patients continue to face. Epilepsy affects over 50 million people worldwide, yet many still lack effective seizure control. Care today often relies on short EEG snapshots and retrospective reporting — approaches that fall short for a continuous neurological condition. At Mentis Care, we

A multi-year Sponsored Research Agreement with Emory’s School of Medicine to build a transformer-based EEG foundation model that works reliably across clinical and wearable settings, addressing a persistent barrier to real-world epilepsy care. TORONTO, ON – March 16, 2026 – Mentis Care, an AI-driven neuromonitoring company, today announced a two-year research collaboration with Emory University to develop channel-agnostic AI models

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025  — SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and commercialization of treatments for disorders of the central nervous system (CNS) and oncology worldwide, today announced the establishment of Mentis Care, Inc., a joint